Cargando…

Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation

BACKGROUND: Though viewed as a potentially safer palliative alternative to opioids, studies of cannabis use for inflammatory bowel disease (IBD) are limited. The impact of opioids on hospital readmissions for IBD has been extensively examined, but cannabis has not been similarly studied. Our goal wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oseni, Ellen A., Blumenthal, Miriam, Izard, Stephanie, Qiu, Michael, Mone, Anjali, Swaminath, Arun, Sultan, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990718/ https://www.ncbi.nlm.nih.gov/pubmed/36895626 http://dx.doi.org/10.14740/jocmr4846

Ejemplares similares

Factors Influencing Thirty-Day Readmission Rate in Patients With Heart Failure Exacerbation
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020)

Ninety-day readmissions following reverse total shoulder arthroplasty
por: Scott, Kelly L., et al.
Publicado: (2019)

Ninety-day readmissions after inpatient cholecystectomy: A 5-year analysis
por: Manuel-Vázquez, Alba, et al.
Publicado: (2017)

Ninety-Day Readmission in Elective Revision Lumbar Fusion Surgery in the Inpatient Setting
por: Hydrick, Thomas C., et al.
Publicado: (2019)

Thirty‐day readmission after spontaneous intracerebral hemorrhage
por: Bjerkreim, Anna Therese, et al.
Publicado: (2018)

Risk factors for ninety-day readmission following cervical surgery: a meta-analysis
por: Wang, Dongping, et al.
Publicado: (2022)

Ninety-two days /
por: Waugh, Evelyn, 1903-1966

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
por: Nocerino, Angelica, et al.
Publicado: (2019)

Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database
por: Morita, Yusuke, et al.
Publicado: (2019)

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
por: Buckley, Megan C., et al.
Publicado: (2021)

Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope
por: Siddappa Malleshappa, Sudeep K., et al.
Publicado: (2020)

An Analysis of Factors Associated With Readmission Within Ninety Days From a Community Mental Health Rehabilitation Team
por: White, Ursula, et al.
Publicado: (2023)

Thirty-Day Readmission Rates in Orthopedics: A Systematic Review and Meta-Analysis
por: Bernatz, James T., et al.
Publicado: (2015)

Thirty-day Complications and Readmission Rates in Elderly Patients After Shoulder Arthroplasty
por: Koh, Justin, et al.
Publicado: (2018)

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients
por: Mozaffari, E, et al.
Publicado: (2022)

Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
por: Kichloo, Asim, et al.
Publicado: (2022)

Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
por: Jang, Sun-Joo, et al.
Publicado: (2021)

Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database
por: Jha, Anil Kumar, et al.
Publicado: (2022)

The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
por: Okeke, Francis, et al.
Publicado: (2020)

The number of discharge medications predicts thirty-day hospital readmission: a cohort study
por: Picker, David, et al.
Publicado: (2015)

Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions
por: Schachne, Jonathan M, et al.
Publicado: (2021)

Independent Predictors and Causes of Thirty-Day Gastrointestinal Readmissions Following COVID-19-Related Hospitalizations: Analysis of the National Readmission Database
por: Kwei-Nsoro, Robert, et al.
Publicado: (2023)

Thirty-day readmission rates and associated risk factors after coronary artery bypass grafting
por: Alghafees, Mohammad A., et al.
Publicado: (2020)

Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based Data
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2020)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
por: Lau, Christine SM, et al.
Publicado: (2017)

Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19
por: Sultan, Keith, et al.
Publicado: (2021)

Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis
por: Mumtaz, Khalid, et al.
Publicado: (2020)

Thirty-Day Hospital Readmissions: A Predictor of Higher All-cause Mortality for Up to Two Years
por: Shaw, Jawaid A, et al.
Publicado: (2020)

Thirty-Day Unplanned Readmission After Ambulatory Laparoscopic Cholecystectomy in Western China: A Retrospective Study
por: MingJun, Huang, et al.
Publicado: (2021)

Thirty‐day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation
por: Tennison, Jegy M., et al.
Publicado: (2021)

Perioperative Stroke and Thirty-Day Hospital Readmission After Cardiac Surgeries: State Inpatient Database Study
por: Alrifai, Nada, et al.
Publicado: (2022)

Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
por: Dahiya, Dushyant Singh, et al.
Publicado: (2022)

Thirty-Day readmissions among COVID-19 patients hospitalized during the early pandemic in the United States: Insights from the Nationwide Readmissions Database
por: Muzammil, Taimur Sohail, et al.
Publicado: (2023)

Case of Inversio Uteri Successfully Reduced on the Ninety-Third Day
por: Miller, Hugh
Publicado: (1851)

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
por: Prabhu, Vimalanand S, et al.
Publicado: (2017)

Thirty-Day Readmission After Elective Colorectal Surgery for Colon Cancer: A Single-Center Cohort Study
por: Chung, Jun Seong, et al.
Publicado: (2020)

Thirty-day hospital readmission prediction model based on common data model with weather and air quality data
por: Ryu, Borim, et al.
Publicado: (2021)

Correction to: Perioperative Stroke and Thirty-Day Hospital Readmission After Cardiac Surgeries: State Inpatient Database Study
por: Alrifai, Nada, et al.
Publicado: (2022)

A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application
por: Becher, Noah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hg8e6q70dg6nmno4de6im3lrvm